Key opinion leaders explore the clinical and economic burden of dementia-related psychosis and the unmet medical need.
An overview of dementia-related psychosis and the associated risk factors is provided. Stephen A. Brunton, MD, and Gary W. Small, MD, discuss the presentation of patients with dementia-related psychosis in their respective practices, as well as the stage of disease that patients are usually referred to a specialist. Dr Brunton then considers the impact of treatment delays on patients with dementia-related psychosis and their caregivers.
The speakers are paid consultants on behalf of Acadia Pharmaceuticals Inc. This is a disease-awareness, non-CME program sponsored by Acadia Pharmaceuticals Inc.